L2 Bio, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease (NCT07010926) | L2 Bio, LLC | 2025-08-15 |
Track L2 Bio, LLC automatically
Every clearance here is in the API, with alerts when new ones post.